Lexicon Pharmaceuticals

LXRX

Börsenwert 663 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
76	76 AllianceBernstein Nashville, Tennessee	105.768 $	+132.068 $	+67.800	Neu
77	77 Winton Group London, United Kingdom	103.680 $	+34.478 $	+17.700	+69 %
78	78 INTECH Investment Management West Palm Beach, Florida	101.978 $	+82.768 $	+42.491	Neu
79	79 LMR Partners London, United Kingdom	98.618 $	+34.645 $	+17.786	+76 %
80	80 Bank of Montreal Toronto, Ontario, Canada	96.000 $	-58.437 $	-30.000	-43 %
81	81 BNP Paribas Financial Markets Paris, France	90.672 $	+39.406 $	+20.230	+115 %
82	82 Rafferty Asset Management New York	81.816 $	+66.404 $	+34.090	Neu
83	83 ProShare Advisors Bethesda, Maryland	78.212 $	+63.478 $	+32.588	Neu
84	84 Leonteq Securities AG Zurich, Switzerland	72.000 $	–	–	–
85	85 Pathstone Holdings Englewood, New Jersey	71.925 $	+380 $	+195	+0,7 %
86	86 Pinnacle Associates New York	69.636 $	–	–	–
87	87 Security National Bank of Sioux City Iowa Sioux City, Iowa	63.960 $	–	–	–
88	88 Victory Capital Management San Antonio, Texas	58.135 $	+3.008 $	+1.544	+7 %
89	89 Legal & General Group London, United Kingdom	58.044 $	+47.110 $	+24.185	Neu
90	90 Xponance Philadelphia, Pennsylvania	57.031 $	+46.288 $	+23.763	Neu
91	91 Graham Capital Management Rowayton, Connecticut	56.498 $	-20.426 $	-10.486	-31 %
92	92 Ameritas Investment Partners Lincoln, Nebraska	55.166 $	+44.774 $	+22.986	Neu
93	93 D.E. Shaw & Co New York	53.280 $	+43.243 $	+22.200	Neu
94	94 Quadrature Capital London, United Kingdom	52.795 $	-172.157 $	-88.381	-80 %
95	95 Wedbush Securities Los Angeles, California	48.000 $	-40.614 $	-20.850	-51 %
96	96 Diker Management New York	48.000 $	–	–	–
97	97 Invera Wealth Advisors Bend, Oregon	48.000 $	–	–	–
98	98 TIAA-CREF Individual & Institutional Services New York	48.000 $	–	–	–
99	99 Russell Investments Group London, United Kingdom	47.764 $	+38.767 $	+19.902	Neu
100	100 Tower Research Capital (TRC) New York	46.766 $	+37.957 $	+19.486	Neu

Lexicon Pharmaceuticals LXRX Börsenwert 663 Mio. $

Lexicon Pharmaceuticals

LXRX

Börsenwert 663 Mio. $